Related Experiment Video
Updated: Jan 6, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[Molecular classification and its clinical relevance in diffuse large B-cell lymphoma]
1Department of Hematology and Oncology, Okayama University Hospital.
Discovering novel genetic abnormalities in diffuse large B-cell lymphoma (DLBCL) aids in developing targeted therapies. This research explores patient stratification based on these genetic findings for precision medicine.
Area of Science:
- Hematology
- Oncology
- Molecular Genetics
Background:
- Hematopoietic tumors encompass diverse diseases, with B-cell lymphomas being a significant group.
- Diffuse large B-cell lymphoma (DLBCL) is a complex entity with various suspected molecular genetic drivers.
- The WHO classification system categorizes numerous B-cell lymphoma subtypes.
Purpose of the Study:
- To highlight the significance of recent advancements in genetic analysis technology for DLBCL research.
- To discuss the discovery of novel and recurrent genetic abnormalities in DLBCL.
- To explore the potential for patient stratification based on genetic profiles in DLBCL.
Main Methods:
- Review of recent developments in genetic analysis technology.
- Analysis of discovered novel and recurrent genetic abnormalities in DLBCL.
- Exploration of genetic data for patient stratification strategies.
Main Results:
- Identification of novel and recurrent genetic abnormalities in DLBCL.
- Demonstration of the importance of genetic findings for therapeutic drug development.
- Establishment of the potential for genetic abnormality-based patient stratification.
Conclusions:
- Genetic abnormalities play a crucial role in DLBCL tumorigenesis.
- New genetic discoveries pave the way for targeted therapies and precision medicine in DLBCL.
- Patient stratification by genetic profile is a promising approach for DLBCL treatment.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
Related Concept Videos
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Differentiation of Common Myeloid Progenitor Cells
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...